Ikka 250mg Injection
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Ikka 250mg Injection
Cefazolin 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, bones, joints, lungs (such as pneumonia), brain, and bloodstream. This antibiotic is also prophylactically administered to hospitalized individuals to ward off infections. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, at consistent intervals, is crucial. Complete the entire course, even with symptom improvement, as premature cessation risks relapse or exacerbation. Common side effects may encompass injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or lack of improvement warrant medical consultation. High doses may rarely cause dizziness, kidney impairment, and hearing deficits; thus, rigorous adherence to physician instructions is mandatory, possibly including regular kidney function, hearing, and urinalysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Primary Ingredients of Ikka 250mg Injection
No text provided to rephrase.
Uses of Ikka 250mg Injection
Infections caused by bacteria
Major Benefits of Ikka 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ikka 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Ikka 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ikka 250mg Injection works:
The antibiotic injection Ikka 250mg inhibits bacterial proliferation by blocking the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of alcohol and Ikka 250mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Ikka 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, in exceptional, life-threatening circumstances where the potential advantages outweigh the hazards, a physician might exceptionally authorize its use. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Ikka 250mg poses no known breastfeeding risk. Research in humans indicates minimal to negligible transfer into breast milk, suggesting no infant harm.
DrivingUNSAFE
Administering Ikka 250mg Injection may induce drowsiness, blurred vision, or dizziness. Driving is inadvisable should these effects manifest.
KidneyCAUTION
The administration of Ikka 250mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Ikka 250mg Injection might be necessary. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Ikka 250mg Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Ikka 250mg Injection :
Omit a scheduled Ikka 250mg Injection? Seek medical advice immediately.
Facts to Know About Ikka 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently